Resultados de la búsqueda 81 – 100 de 367
Reproductive Options When One or Both Partners Have HIV
Appendix B: Safety and Toxicity of Individual Antiretroviral Agents in Pregnancy
Non-Nucleoside Reverse Transcriptase Inhibitors
Tables
Table 4. Significant Pharmacokinetic Interactions Between Drugs Used to Treat or Prevent Opportunistic Infections
Guidelines Panel Members
Archived Drugs
Amprenavir (Agenerase, APV)
Cytomegalovirus Disease
Limitations to Treatment Safety and Efficacy
Adherence to the Continuum of Care
Appendix B: Mycobacterium tuberculosis
Considerations for Antiretroviral Use in People With Coinfections
Tuberculosis/HIV Coinfection
Appendix A: Key to Acronyms
Appendix A: Drug Name Abbreviations
Antepartum Care
Indinavir (Crixivan, IDV)
Appendix A: Pediatric Antiretroviral Drug Information
Pharmacokinetic Enhancers